REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIA
- 1 July 1980
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 316 (8187) , 170-172
- https://doi.org/10.1016/s0140-6736(80)90060-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 CasesBritish Journal of Haematology, 1980
- Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.Proceedings of the National Academy of Sciences, 1979
- Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.Journal of Clinical Investigation, 1978
- In vivo toxicity to lymphoid tissue by 2?-DeoxycoformycinCancer Chemotherapy and Pharmacology, 1978
- TERMINAL DEOXYNUCLEOTIDYL-TRANSFERASE LEVELS AND MEMBRANE PHENOTYPES IN DIAGNOSIS OF ACUTE LEUKÆMIAThe Lancet, 1977
- Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitorsBiochemical Pharmacology, 1977
- Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.Journal of Clinical Investigation, 1976
- Chronic Granulocytic Leukaemia: Multiple-drug Chemotherapy for Acute TransformationBMJ, 1974
- Pyrimidine Starvation Induced by Adenosine in Fibroblasts and Lymphoid Cells: Role of Adenosine DeaminaseScience, 1973
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972